Moomoo AI 已提取核心信息
Cassava Sciences, Inc., a biotechnology company based in Austin, Texas, has announced the registration of warrants for purchase of its common stock with the United States Securities and Exchange Commission (SEC). These warrants, expiring on or before November 15, 2024, will be distributed to shareholders of record as of December 22, 2023. The distribution of the warrants is set to occur on or about January 3, 2023. Each warrant entitles the holder to purchase shares of Cassava Sciences' common stock at a price of $33.00, along with an additional 0.5 share per warrant exercised before the Bonus Share Expiration Date. The company has applied to list these warrants on The Nasdaq Capital Market under the symbol 'SAVAW'. Cassava Sciences has also outlined the conditions under which the warrants...Show More
Cassava Sciences, Inc., a biotechnology company based in Austin, Texas, has announced the registration of warrants for purchase of its common stock with the United States Securities and Exchange Commission (SEC). These warrants, expiring on or before November 15, 2024, will be distributed to shareholders of record as of December 22, 2023. The distribution of the warrants is set to occur on or about January 3, 2023. Each warrant entitles the holder to purchase shares of Cassava Sciences' common stock at a price of $33.00, along with an additional 0.5 share per warrant exercised before the Bonus Share Expiration Date. The company has applied to list these warrants on The Nasdaq Capital Market under the symbol 'SAVAW'. Cassava Sciences has also outlined the conditions under which the warrants can be redeemed and the adjustments applicable to the Basic Warrant Exercise Rate and the Bonus Share Expiration Trigger Price. The company will provide public notice prior to any redemption or expiration event related to the warrants. The distribution of the warrants is part of a dividend issuance and has not been registered under the Securities Act, with the company planning to file a prospectus supplement for the shares of common stock underlying the warrants.
总部位于德克萨斯州奥斯汀的生物技术公司Cassava Sciences, Inc. 宣布在美国证券交易委员会（SEC）注册购买其普通股的认股权证。这些认股权证将于2024年11月15日当天或之前到期，将分配给截至2023年12月22日的登记股东。认股权证的分配定于2023年1月3日左右进行。每份认股权证使持有人有权以33.00美元的价格购买Cassava Sciences的普通股，并在红股到期日之前行使的每份认股权证额外购买0.5股。该公司已申请在纳斯达克资本市场上市，股票代码为 “SAVAW”。Cassava Sciences还概述了赎回认股权证的条件以及适用于基本认股权证行使率和红股到期触发价格的调整。公司将在与认股权证相关的任何赎回或到期事件之前发布公告。认股权证的分配是股息发行的一部分，尚未根据《证券法》进行登记，该公司计划提交认股权证所依据普通股的招股说明书补充文件。
总部位于德克萨斯州奥斯汀的生物技术公司Cassava Sciences, Inc. 宣布在美国证券交易委员会（SEC）注册购买其普通股的认股权证。这些认股权证将于2024年11月15日当天或之前到期，将分配给截至2023年12月22日的登记股东。认股权证的分配定于2023年1月3日左右进行。每份认股权证使持有人有权以33.00美元的价格购买Cassava Sciences的普通股，并在红股到期日之前行使的每份认股权证额外购买0.5股。该公司已申请在纳斯达克资本市场上市，股票代码为 “SAVAW”。Cassava Sciences还概述了赎回认股权证的条件以及适用于基本认股权证行使率和红股到期触发价格的调整。公司将在与认股权证相关的任何赎回或到期事件之前发布公告。认股权证的分配是股息发行的一部分，尚未根据《证券法》进行登记，该公司计划提交认股权证所依据普通股的招股说明书补充文件。
有用
没用